Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site-Reference-Cited by-同舟云学术

Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site

Published:2017-11 Issue: Volume:266 Page:187-197
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Zhao Min,Rodríguez-Villagra Esther,Kowalczuk Laura,Le Normand Manon,Berdugo Marianne,Levy-Boukris Rinath,El Zaoui Ikram,Kaufmann Béatrice,Gurny Robert,Bravo-Osuna Irene,Molina-Martínez Irene T.,Herrero-Vanrell Rocío,Behar-Cohen Francine

Funder

Agence Nationale de la Recherche

Fondation de la Recherche Médicale

Spanish Ministry of Economy, Industry and Competitiveness

Instituto de Salud Carlos III

Complutense Research Group

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?;Farman;Exp. Dermatol.,2010

2. Extrarenal effects of aldosterone;Nguyen Dinh Cat;Curr. Opin. Nephrol. Hypertens.,2012

3. Vascular actions of aldosterone;Briet;J. Vasc. Res.,2013

4. Vascular effects of aldosterone: sorting out the receptors and the ligands;Feldman;Clin. Exp. Pharmacol. Physiol.,2013

5. Mineralocorticoid receptors in vascular function and disease;McCurley;Mol. Cell. Endocrinol.,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball;Materials Today Bio;2024-08

2. A Clinical, Pharmacological, and Formulation Evaluation of Melatonin in the Treatment of Ocular Disorders—A Systematic Review;International Journal of Molecular Sciences;2024-04-03

3. Spironolactone Eyedrop Favors Restoration of Corneal Integrity after Wound Healing in the Rat;Pharmaceuticals;2023-10-12

4. Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress;Journal of Nanobiotechnology;2023-03-10

5. Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy;International Journal of Molecular Sciences;2023-01-25